semaglutide weight gain Semaglutide, a second-generation GLP-1 receptor agonist, was associated with significantly reduced body and other metabolic factors in adults with schizophrenia, prediabetes, and overweight/obesity compared with placebo, research from September GLP-1 prevention of heart disease

GLP-1 medicines such as semaglutide and tirzepatide work with your body's own signaling to influence appetite and how full you feel

What Is SLM+ for Healthy Weight Management

The Role of Healthcare Professionals in Managing Side Effects Doctor or pharmacist consultation remains essential for proper side effect management

The evidence regarding why some patients experience persistent sugar cravings while others do not continues to evolve, with ongoing research examining these differences

Ensuring sufficient caloric intakeeven during appetite suppressionsupports metabolic stability and thermoregulation

Research supports its potential to help improve mental function in older adults with Alzheimers disease and mild cognitive impairment